Innovations in Human Enablement and Enhancement Technologies
|出版商||Frost & Sullivan||商品編碼||355852|
|出版日期||內容資訊||英文 71 Pages
|人類強化技術的革新 Innovations in Human Enablement and Enhancement Technologies|
|出版日期: 2016年03月30日||內容資訊: 英文 71 Pages||
本報告提供人類強化技術的現況與未來展望相關分析，代表性技術 - 腦機介面，外骨骼，電力藥學，促智藥 - 的概要，及目前技術水準，主要企業、產品，全球各地的技術普及預測，今後的技術開發預測與市場機會等相關調查與考察。
Interface technologies trigger novel opportunities
The overall purpose of human enablement is to restore an impaired function to average levels but mostly to raise the current level that is beyond the norm for humans. The current research service on human enablement covers the most talked about technologies of the present and future - Brain-Computer Interfaces (BCIs), Exoskeletons, Nootropics and Electroceuticals. This research service covers these four technologies in detail, profiling key industry players and their products, their innovation attributes and the factors associated with their likelihood of adoption. The section on impact assessment lists the top industry drivers and challenges that are expected to encourage the adoption of these technologies. The subsequent section on diffusion of innovations provides a detailed breakup of the factors associated with adoption of each of the technologies in three of the most prominent regions of the world - North America, Europe and Asia-Pacific. Finally, the chapter on opportunity analysis recommends some of the key management strategies that must be embraced to boost the current state of human enhancement technologies. This segment also lists some of the key technologies and applications that will begin to make inroads in the global market by 2025.